(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: ( |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Names of Nominee | Votes For | Votes Withheld | Broker Non-Votes | |||||||||||||||||
Cynthia Lucchese | 35,340,330 | 10,698,171 | 5,311,980 | |||||||||||||||||
Jonathan Root, M.D. | 32,079,459 | 13,959,042 | 5,311,980 | |||||||||||||||||
Robert Warner | 45,664,293 | 383,013 | 5,303,175 |
Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
51,013,353 | 284,978 | 52,150 | 0 |
Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
42,519,009 | 3,417,294 | 111,003 | 5,303,175 |
INARI MEDICAL, INC. | |||||||||||
Date: | May 19, 2023 | By: | /s/ Mitchell Hill | ||||||||
Mitchell Hill Chief Financial Officer |
Cover |
May 18, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 18, 2023 |
Entity Registrant Name | Inari Medical, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-39293 |
Entity Tax Identification Number | 45-2902923 |
Entity Address, Address Line One | 6001 Oak Canyon |
Entity Address, Address Line Two | Suite 100 |
Entity Address, City or Town | Irvine |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92618 |
City Area Code | 877 |
Local Phone Number | 923-4747 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.001 par value |
Trading Symbol | NARI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Flag | false |
Entity Central Index Key | 0001531048 |
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end
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